SG Americas Securities’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-42,121
| Closed | -$278K | – | 2844 |
|
2025
Q1 | $278K | Sell |
42,121
-7,918
| -16% | -$52.3K | ﹤0.01% | 2028 |
|
2024
Q4 | $436K | Buy |
+50,039
| New | +$436K | ﹤0.01% | 1278 |
|
2024
Q2 | – | Sell |
-5,174
| Closed | -$110K | – | 2632 |
|
2024
Q1 | $110K | Buy |
+5,174
| New | +$110K | ﹤0.01% | 2205 |
|
2023
Q3 | – | Sell |
-36,983
| Closed | -$391K | – | 2811 |
|
2023
Q2 | $391K | Buy |
36,983
+9,858
| +36% | +$104K | ﹤0.01% | 1329 |
|
2023
Q1 | $332K | Buy |
27,125
+18,383
| +210% | +$225K | ﹤0.01% | 1866 |
|
2022
Q4 | $108K | Buy |
8,742
+35
| +0.4% | +$432 | ﹤0.01% | 2420 |
|
2022
Q3 | $119K | Sell |
8,707
-46,212
| -84% | -$632K | ﹤0.01% | 2439 |
|
2022
Q2 | $1.01M | Sell |
54,919
-42,562
| -44% | -$780K | 0.01% | 1153 |
|
2022
Q1 | $1.57M | Sell |
97,481
-77,370
| -44% | -$1.24M | 0.01% | 950 |
|
2021
Q4 | $2.45M | Buy |
174,851
+56,550
| +48% | +$792K | 0.01% | 848 |
|
2021
Q3 | $2.22M | Buy |
118,301
+18,651
| +19% | +$349K | 0.01% | 1063 |
|
2021
Q2 | $2.08M | Buy |
99,650
+838
| +0.8% | +$17.5K | 0.01% | 997 |
|
2021
Q1 | $2.79M | Buy |
98,812
+9,751
| +11% | +$276K | 0.01% | 744 |
|
2020
Q4 | $2.91M | Sell |
89,061
-12,763
| -13% | -$417K | 0.02% | 727 |
|
2020
Q3 | $3.12M | Buy |
101,824
+47,012
| +86% | +$1.44M | 0.02% | 403 |
|
2020
Q2 | $893K | Buy |
54,812
+39,693
| +263% | +$647K | 0.01% | 1285 |
|
2020
Q1 | $150K | Buy |
15,119
+7,107
| +89% | +$70.5K | ﹤0.01% | 2287 |
|
2019
Q4 | $110K | Sell |
8,012
-95,826
| -92% | -$1.32M | ﹤0.01% | 2498 |
|
2019
Q3 | $1.58M | Buy |
103,838
+96,885
| +1,393% | +$1.47M | 0.01% | 987 |
|
2019
Q2 | $137K | Buy |
+6,953
| New | +$137K | ﹤0.01% | 2259 |
|